Browsing: or as the only test to make a diagnosis for Alzheimer’s disease. Additional testing should be done to determine treatment options.

       The Lumipulse blood test became the first “in vitro diagnostic device” to be endorsed by the U.S. Food and Drug Administration, which cleared it earlier this month as a new tool in diagnosing Alzheimer’s disease.